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Summary.-The immunogenicity of murine leukaemias induced by chemical car-
cinogens or irradiation in C57B1 or (C57B1 x DBA2) Fl hybrid mice has been
studied in vivo by transplantation and in vitro byindirect membrane immunofluores-
cence (IF) using syngeneic immune or allogeneic immune antisera. Two of 5
leukaemias tested for immunogenicity by assessment of the capacity of syngeneic
mice specifically immunized with irradiated (3 Krad) cells to reject small challenge
inocula (103-104 cells) displayed weak neoantigenicity while 3 were non-immuno-
genic by this criterion. Antibodies directed against cell-surface antigens of the
immunizing cells of 7 leukaemias were not detectable by immunofluorescence tests
using sera from the respective immunized mice. H-2 histocompatibility antigens
readily identified on normal lymphoid cells using reference Balb/c anti-C57B1
(H-2d anti-H-2b) alloantisera could neither be detected on the majority of trans-
planted leukaemias nor on 9 primary leukaemias in C57BL mice induced by N-butyl-
N-nitrosourea (BNU). Two of the transplanted leukaemias showed greatly dimin-
ished capacity for absorption of alloantibody compared with normal spleen cells.
Transplantation to H-2 different recipients, in which the leukaemic cells were
invariably rejected, generated a strong humoral antibody response, which was
demonstrable against normal lymphoid cells.
Failure to demonstrate significant antibody binding by indirect immunofluores-
cence tests with immune sera, or by absorption, is presented as evidence that H-2
antigen expression is substantially modified on BNU induced leukaemia cells.
These findings have implications for the detection of tumour neoantigens on chemi-
cally induced leukaemias.
MALIGNANT transformation is accom-
panied by a number of cell-surface
modifications (Doljanski, 1973). Such
changes may include expression ofneoanti-
gens which are clearly demonstrable by
rejection of transplanted tumour cells in
appropriately immunized hosts and by
different serological procedures, as well as
variations in the expression of normal
histocompatibility antigens (Haywood
and McKhann, 1971; Baldwin and Glaves,
1972). Studies on neoantigen expression
have been extended in recent years to
many diverse host tumour systems (Klein,
1968) while modification of normal cell
surface components has received less
attention (Seigler et al., 1971).
In experimental leukaemogenesis, cell
surface antigenic changes in neoplasms
induced by oncornaviruses have been
relatively well documented (Aoki et al.,
1970; Aoki and Takahashi, 1972; Boyse
and Old, 1969; Stockert, Old and Boyse,
1971). Information on the cell surface
antigenic properties of chemically induced
leukaemias other than those with a long
history of transplantation (Rubin et al.,
1970) is more restricted. However,
quantitative variations in cell-surface anti-
gens specified by the principal mouse
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histocompatibility locus (H-2) on murine
leukaemias inducedby 7, 12-dimethylbenz
(a)anthracene, have been described
recently (Motta and Bruley, 1973).
The objective ofthe present study was
to examine the nature of the antigenic
changes in the cell surface of murine lym-
phoid cells which hadundergone malignant
transformation in vivo byN-butyl-N-nitro-
sourea (BNU). Data initially acquired
from transplantation tests in syngeneic
hosts indicated that new cellular antigens
could not be unequivocally detected on
the surface of several leukaemias induced
by this compound or on one leukaemia of
radiogenic origin. These findings promp-
ted a more extensive enquiry into whether
the determination of neoantigenicity
might be influenced, at least in part, by
more complex changes at the cell surface
affecting expression of normal histocom-
patibility antigens.
MATERIALS AND METHODS
Mice.-Inbred C57B1/6J and DBA2/J
mice were originally obtained from the Jack-
son Laboratory and maintained in our own
colony by brother-sister mating. B6D2F, (hereafter referred to as BDF1) mice are the
Fl progeny of C57B1/6J female mice and
DBA2/J males and were bred at the Paterson
Laboratories.
Leukaemias.-Details of the 8 transplant-
ed leukaemias used in these experiments are
given in Table I. Leukaemia lines were
maintained in vivo by serial intravenous
inoculation ofsyngeneic mice with 106 leukae-
mic spleen cells about every 10 days.
Primary leukaemias were induced in
C57B1 and BDF1 mice by continuous oral
administration of N-butyl-N-nitrosourea
(BNU) in the drinking water at a dose level
of 200 mg/1-1. To each litre of BNU solu-
tion IN HCl (1 ml) and commercial Milton
solution (1 ml) were added giving a pH of 4,
to stabilize the compound. In this solution
97% of the BNU remained unchanged after
3 days at room temperature. The mice were
given fresh solution 3 times each week. This
treatment resulted in a 100% incidence of
leukaemia, with a mean induction time of
about 130 days.
The most common morphological features
of these leukaemias were a large thymic
tumour, which occurred in 65% ofthe treated
animals, and splenomegaly which was also
seen in 65%. Lymph node involvement
was not very marked and occurred in 31%
of BNU treated mice. Hepatomegaly was
lessfrequent and was foundin only26%ofthe
mice.
Transplantation immunity studies
Five leukaemia lines, HII, HIV, CV, RI
and P388 were used and cell suspensions
prepared from normal and leukaemic spleens
were subjected to 3 Krad y-radiation to pro-
duce mitotic inactivationt. Groups of syn-
TABLE I. Transplanted Leukaemias
Leukaemia Mouse strain Derivation Time maintained
AI C57B1 BNU induced 18 months
Cv C57B1 BNU induced 14 months
EII C57B1 BNU induced 14 months
RI C57B1 Radiation induced 14 months
HII BDF1 BNU induced 12 months
HIV BDFI BNU induced 12 months
MNUI BDF1 MNU induced 12 months
P388* DBA2 Originally induced by* 15 months
3-methylcholanthrene in vivo
* P388 leukaemia was derived from a 3-methylcholanthrene induced lymphoid tumour in a DBA2 mouse
which was converted to ascitic form in the first transfer (Dawe and Potter, 1957). P388 cells have been
cultured in suspension in vitro at the Paterson Laboratories for a number of years (Fox and Gilbert, 1966)
but will grow as a lymphoid tumour when injected intravenously into DBA2 mice.
t A measure of the sensitivity ofa cell to radiation is obtained from the Do value of the survival curve.
The Do is invers3ly proportional to the slope of the exponential part ofthe survival curve. and corresponds
to the dose necessary to reduce survival by a factor of l/e. For mammalian lymphoid cells the Do is app-
roximately 100 rad. A dose of 3 Krad (30 x Do) would reduce the survival by a factor of 12 log cycles,
measured in the survival curve. Less than 1 cell per 10 would thus be expected to survive following
exposure to this dose.
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geneic mice were given 4 inoculations of
either 107 or 108 inactivated leukaemic cells
i.p. at 10-day intervals. P388 leukaemia
originated in DBA2 mice and the recipients
in this case were BDF1 mice which are
DBA2 Fl hybrids. Ten days after the final
immunization the mice were challenged with
viable leukaemic cells identical to the immu-
nizing leukaemias. The challenge inocula
were 104 and 103 cells for mice immunized
with 4x108 cells and 103 and 102 cells for
mice which received 4 x 107 cells. Control
groups of non-immune mice, or mice immu-
nized with comparable numbers of normal
spleen cells, were challenged with identical
leukaemic cell inocula.
The mouse boxes were examined daily and
mortalities were recorded. The mean sur-
vival time for each experimental group was
calculated and compared with that of the
controls.
A further 8 groups of 5 mice each were
immunized with 4 doses of 107 radiation
inactivated syngeneic leukaemic cells accord-
ing to the above schedule. The leukaemia
lines Al and ElI were used in addition to the
above 5 lines. Ten days after the final
injection the mice were bled from the retro-
orbital venous plexus and the syngeneic
leukaemic antisera were separated and stored
at -20°C. A normal serum control for each
leukaemia was included. The reactivity of
these sera with the respective immunizing
leukaemias was tested by indirect membrane
immunofluorescence (IF).
Immunofluorescence studies
Cell suspensions ofhigh viability (>95%)
were prepared from normal lymphoid organs
and from grossly macroscopically involved
leukaemic tissue by a teasing technique
followed by passsage through fine metal
gauze to remove non-dissociated material.
The method modified by Moller (1961) for
use with cells in suspension was employed.
Aliquots of 1 ml of cell suspension, con-
taining 5 x 106 to 107 cells ml-1 were centri-
fuged at 800 g for 3 min in small glass tubes.
The cells were washed once in PBS and sedi-
mented by centrifugation as before. Anti-
serum (0-1 ml ) was added to each tube. The
cellswerere-suspendedinserumandincubated
at 4°C for 20 min and then washed 3 times in
PBS. Fluoresceinated horse anti-mouse IgG
(Progressive Laboratories Inc., Baltimore,
USA) was diluted - and 0 1 ml was added to
each tube. The cells were re-suspended and
incubated for 20 min as before. After a
further 3 washings 0 1 ml 50% glycerol-saline
(v/v) solution was added to each tube and the
cells were examined under a coverslip using a
Wild M20 fluorescence microscope, equipped
with an HBO 200 mercury vapour lamp and
the following filters: heat absorbing filter
KG1; u.v. fluorescence exciting filter UGI
(twice) and FITC; red absorbing filter BG38
and a colourless barrier filter, GG13c.
Cells exhibiting degrees of membrane
staining from more than 2 isolated points on
the cell surface to complete ring reactions
were scored as positive.
A total of about 200 cells per tube were
counted and the fluorescence index for each
was calculated from the formula:
Fluorescence Index (Fl)=
%unstainedcellsincontrol-%unstainedintest
% unstained in control
H-2 alloantisera.-Antisera were raised pri-
marilyagainst antigens ofthe principal mouse
histocompatibility locus (H-2). The H-2
genotypes ofthe donor and recipient mice are
given in Table II. Allogeneic mice were
immunized with a minimum of 4 i.p. inocu-
lations of 107 donor spleen cells at 10-day
intervals. The mice were bled 10 days after
the final immunization and the separated
sera from identical groups of mice were
pooled. Fluorescence indices for neat
alloantisera were invariably >0 95, but
diminished to 01 at dilutions of 1/100 or
greater. Routinely, alloantisera were used
at a 1 dilution which gave FT values
against normal spleen cells in the range 0-6 to
0-8.
Alloantisera against 3 leukaemias trans-
planted in syngeneic C57B1 (H-2b) mice
(Al, RI and CV) were raised by a similar
immunization schedule in which Balb/c (H-2d)
mice received 4 i.p. injections of 107 viable
leukaemic spleen cells at intervals of 10 days.
The sera were then tested by indirect IF
against normal C57B1 spleen cells and the
respective immunizing leukaemia cells and
their reactivity compared with those of the
reference H-2d anti-H-2b alloantisera.
Absorption studies.-Balb/c anti-C57BI
(H-2d anti-H-2b) serum in 0 1 mlaliquots was
absorbed with logarithmic dilutions (104-108)
of the cells of 2 transplanted C57B1 leukae-
632ANTIGENS ON MURINE LEUKAEMIAS
TABLE II. H-loci Genotypes of Mouse Strains
Locus
H-1
b
c
H-2 H-3
d not-a
b -
H-5 H-6 I
a d not-a not-a not-a
Alloantiserum
H-7 used
ot-a None
- Balb/c ainti
C57B1(H-2d
anti H-2b)
a C57B1 anti
Balb/c (H-2b
anti H-2d)
From Hanidbook otn Genetically Standardized Mice. Jackson Laboratory, Bar Harbor, Maine.
mias (RI and CV) and normal C57BI spleen.
Incubation was overnight at 4°C, whence the
absorbed sera were tested by indirect IF for
antibody reactivity against normal C57B1
spleen cells.
RESULTS
Immunogenicity of transplanted leukaemias
in syngeneic hosts
Syngeneic mice were challenged intra-
venously with viable tumour cells to
determine the threshold inoculum for
leukaemia development. In most in-
stances, a minimum of 103 cells was
required to kill the majority of untreated
recipients.
In 2/5 cases (P388 and RI) treatment
of mice with high numbers of irradiated
(3000 rad) syngeneic tumour cells sig-
nificantly increased the number of
survivors following challenge with the
immunizing leukaemias compared with
untreated controls (Table III). For P388,
pretreatment with normal spleen cells
also significantly increased the number of
survivors although this protective effect
was less marked than in the leukaemia
pretreatment group. Mice challenged
with 104 P388 cells were resistant whereas
the maximum degree ofresistance induced
by irradiated RI cells was of the order of
103 cells and was not reproducible. Immu-
nization with the remaining 3 leukaemias
(CV, HII and HIV) failed to disclose
significant differences between the various
experimental groups either in respect of
the incidence or latent period of leukaemia
development.
45
Detection of cell surface antigens on trans-
planted leukaemias by indirect membrane
immunoftuorescence (IF)
Fluoresceinated anti-mouse IgG. Cells
derived from normal spleens reacted
directly in the IF test with fluoresceinated
anti-mouse IgG with characteristic immu-
noglobulin staining of the cell surface.
Thepercentageofcellsstained in 8indepen-
dent preparations was 31 8±86. For
the transplanted and primary carcinogen
induced leukaemias, the proportion of
stained cells depended on the degree of
splenic infiltration with leukaemia cells.
Staining of cells from individual spleens
showing gross leukaemic involvement was
invariably limited to less than 500 of the
total. Where infiltration was lessmarked,
the proportion of cells stained was more
variable but usually well below levels for
normal spleen (Table IV).
Syngeneic antisera.-Sera from mice
pre-treated with irradiated cells of 8 trans-
planted leukaemias were taken and tested
against the corresponding leukaemia cells
used for immunization. Their reactivity
with these cells in the indirect IF test
was compared with sera from normal
untreated mice of the same strain.
In no test was there a significant differ-
ence between the numbers of cells stained
with normal and leukaemic antisera, even
from the minority of mice subsequently
resistant to in vivo challenge (Table III).
The fluorescence indices (FI) ranged from
-0*15 to 0 (mean -0.04±0.07) (Table V).
Alloantisera. H-2 alloantisera from
Strain
Balb/c
C57B1
DBA2
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TABLE IV.-Comparative Staining of Surface Immunoglobulin of C57Bl Leukaemic
and Normial Spleen Cells by Direct Membrane Immunoftuorescence (IF)
Target,
cells
Normal C57B1
spleen
Transplantecd
leukaemias (spleeni)
Primary leukaernias
(spleen)
No. of
tests
8
6
Percentage stained with fluoresceinated
anti-mouse IgG
Range Mean
19-48
2-11
:31 8± 8-6
4-7±33
15 - 3±10- 4
TABLE V. Reactivity by Indirect Membrane Immunoftuorescence of Transplanted
Leukaemic Spleen Cells with Syngeneic Leukaemia Antisera compared with Normal
Mouse Serum (NMS)
Leukaemic target cell
HIV
MNUI
HII
RI
Al
CV
P388
Serum
anti-HIV
NMS
anti-MNU I
NMS
anti-HII
NMS
anti-RI
NMS
anti-Al
NMS
anti-CV
NMS
anti-P388
NMS
% cells unstaine(d
91
89
97
96
95
95
97
98
100
98
97
96
87
90
FI*
-0 02
-0-10
0
0*01
-0 02
-0-01
-0 15
* P in each instance, inot significant.
(Pvalues were obtained for the results of the Chi-squared test on the null hypothesis that the proportion
of cells stained is the same for syngeneic leukaemia antiserum and normal mouse serum.)
TABLE VI.-Reactivity by Indirect Membrane Immunoftuorescence of Transplanted
Leukaemic Spleen Cells with H-2 Alloantisera
Leukaemic target cell
HIV
MNUI
HII
RI
Al
cv
P388
Serum
H-2d anti H-2b
NMS
H-2d anti H-2b
NMS
H-2d anti H-2b
NMS
H-2d anti H-2b
NMS
H-2d anti H-2b
NMS
H-2d anti H-2b
NMS
H-2b anti H-2d
NMS
mice pretreated with viable allogeneic
normal lymphoid cells were tested against
the same 8 transplanted leukaemias and
their reactivity compared with that of sera
from non-immune mice of the appropriate
strain.
In tests with leukaemias HIV, RI and
P388 there was no difference in the number
of stained cells between the H-2 alloanti-
serum and control serum (Table VI). FI
values ranged from 0 04 to 0-06 (mean
0-05±0.01). Significant degrees of
staining with alloantisera compared with
normal mouse serum were obtainedagainst
% unstained
84
89
87
96
89
95
91
95
78
97
91
100
81
84
El
0 06
(- 11
0 06
0-04
0-11
0 09
0 04
p
NS
<0005
<0*025
NS
<0*0005
<0-001
NS
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for the approximately five-fold increase in
size of the leukaemic cells compared with
normal spleen cells.
Comparison of the profiles in Fig. la,b
indicates that for a standard volume of
reference antiserum (H-2d anti H-2b)
significantly greater numbers ofleukaemic
cells were required in both instances to
reduce theFlcomparedwithnormal spleen
cells, notwithstanding the substantially
v 5 6 7 8 9 cells to whlch the alloantiserum was
Log No. Absorbing Cells per ml antiserum exposed.
(a)
1-1
LL
U.
U'
0
L.2
5 o 1 0 7
Log No. Absorbing CelIs per ml antiserum
(b)
FIG. Relative absorption capacities of trans-
planted leukaemia (RI and CV) cells and
normal spleen cells for Balb/c anti-C57BI
(H-2d anti H-2b) alloantiserum. Upperfigure
(a) 0 0, O, RI cells
(duplicate absorptions) *- 0
normal spleen cells. Lower figure (b)
0 O, O, CV cells
(duplicate absorptions) * * nor-
mal spleen cells.
the remaining leukaemias (MNUI, HII,
Al and CV) although the FIs were low
(range, 0 06-011, mean 0-09±0-02)
(Table VI). By contrast, the same alloanti-
sera stained normal lymphoid cells from
mice ofthe respective strains in 3 indepen-
dent tests with FIs in the range 0-73-0-86
(mean 0-79+0-04).
Absorption of alloantiserum. The abi-
lity of leukaemias RI and CV in compari-
son with normal C57B1 spleen cells to
absorb alloantibody was evaluated in a
series of tests. No correction was made
Detection ofcell-surface antigens onprimary
leukaemias by indirect membrane immuno-
fluorescence (IF)
Lymphoid tissues from 9 primary BNU
induced leukaemias arising in C57B1 mice
were tested for H-2 alloantigens with
Balb/c anti-C57BI (H-2d anti H-2b) anti-
serum (Table VII). Leukaemic spleens
from all mice showed markedly dimin-
ished reactivity with the alloantiserum
(mean FL, 0 08±0 08) compared with
lymphoid cells from the spleens of normal
untreated mice (mean Fl 0 68±0 06). In
one example only (LS3) the FL value was
slightly elevated but this was insignificant
compared with the normal spleen controls.
Comparably, the reactivity of leukaemic
thymuses (tested in 6 mice) to the allo-
antiserum was greatly reduced, FIs falling
in the range -0 04-0 11 (mean FL 0.0+
0.08), compared with normal thymocytes
against which the FIs were 0-51-0-72
(mean Fl 0-60±0-11). However, lymph
nodes from 2 leukaemic mice showed in-
creased numbers of stained cells (FIs
0-38 and 0-31) compared with leukaemic
thymuses and spleen, but were still dim-
inished compared with normal lymph
node cells, for which the FL values were
0*68 in separate tests.
Capacity ofleukaemia cells to evokeantibody
production in allogeneic recipients
Alloantisera produced in Balb/c mice
following 2 injections of 107 Al, RI or CV7
leukaemia cells were tested against the
immunizing leukaemia cells and normal
0
LL
V
V)
Vo
VE
LL
i.7
i.6
1.5
i.4
1.2
). I
n I I I i- increasea suriace area OI tne ieuxaemic
I ~ ~ ~ ~ ~ ~ ~ ~ ~ ~~ ~~ ~ ~~~~~ I I I I- l . -l -1 * 1 L1 1 1 . 1 I-
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TABLE VII.-Reactivity by Indirect Membrane Imrnunofluorescence ofPrimary
C57B1 Leukaemias with H-2 Alloantiserum (H-2d anti H-2b)
Target cells
leukaemic spleen
normal spleen
leukaemic thymus
normal thymus
leukaemic lymph node
normal lymph node
leukaemic spleen
normal spleen
leukaemic thymus
normal thymus
leukaemic spleen
normal spleen
leukaemic thymus
normal thymus
leukaemic lymph node
normal lymph node
leukaemic spleen
normal spleen
leukaemic thymus
normal thymus
leukaemic spleen
normal spleen
leukaemic thymus
normal thymus
leukaemic spleen
normal spleen
leukaemic thymus
normal thymus
leukaemic spleen
normal spleen
leukaemic spleen
normal spleen
leukaemic spleen
normal spleen
% Cells unstained
87
22
90
32
55
28
78
30
86
46
67
30
85
46
69
28
86
30
98
46
71
30
93
46
99
30
98
23
86
30
99
30
89
17
* Calculated with respect to NMS value
TABLE VIII.-Reactivity by Indirect Membrane Immnunofluorescence of Allogeneic
Leukaemia Antisera with the Immunizing Leukaemia Cells and Normal
Lymphoid Cells
Immuniization
2 x 107 cells i.p.
4 x 107 cells i.p.
Serum FI versus:-
Al RI CV
0.05 0-02 0
0 53 0-66 0-60
0-01 0 03 0-06
0-86 0 70 0-78
Mouse No.
1
2
3
4
5
6
7
8
Flt
0 02
0 73
010
0-67
0 ,'38
0-68
0 08
0-64
0*10
0-51
0-22
0-64
0*11
0-51
0-31
0-68
0-01
0-64
0 04
0-51
0 - 18
0-64
0 04
0-51
0
0-64
0-01
0-72
0*05
0-64
0-02
0 64
O*11
0-76
Target cells
Leukaemic
Normal
Leukaemic
Normal
Mean Fl
(IS.E.)
0 0210 03
0 60±0 07
0 03±0 03
0 78±0 08
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spleen cells respectively. Without
exception, when leukaemia cells were used
as targets the proportion ofunstained cells
exposed to the leukaemia antisera did not
differ from those treated with normal
mouse serum, FIs ranging from 0 to 0 05
(mean 0 02±0*03) (TableVIII). By con-
trast, eachoftheseantiserareactedstrongly
with normal spleen cells to give FJs from
0 53 to 0-66 (mean 0 60±0 07). The
capacity of the allogeneic leukaemia anti-
sera to stain cells of the immunizing
leukaemias could not be increased by
hyperimmunization (mean Fl 0 03±0.03).
However, higher Fl values ranging from
0 70 to 0-86 (mean Fl 0.78±0 08) were
obtained against normal spleen cells with
these antisera.
DISCUSSION
The disclosure ofsignificant differences
in expression of antigenic components on
the surface of leukaemic and normal mur-
ine lymphoid cells is dependent on reli-
able and sensitive methods for antigen
detection. In the study ofthe cell-surface
antigens of leukaemic cells two techniques
haveprincipallybeenused,viz. complement
dependent immune cytolysis and mem-
brane immunofluorescence (IF). Neither
ofthese methods is without disadvantages;
immune cytolysis is a complex process
dependent not only on antibody binding
but also on complement activation as well
as properties related to membrane vulner-
ability and ability of cells to repair mem-
brane damage (Lerner, Oldstone and
Cooper, 1971). Membrane immuno-
fluorescence, on the other hand, is a
sensitive and technically facile method
although evaluation of results depends on
visual observations that are not readily
quantified. Whilst recognizing these
limitations, the results presented in this
paper were obtained using the latter
technique and purport to show that, in
comparison with normal lymphoid cells,
there is gross modification of surface
antigen expression on radiation and
chemically-induced leukaemiccells. These
conclusions are based principally on the
findings that H-2 alloantisera capable of
detecting H-2 antigens on the surface of
normal cells from different lymphoid
organs with an appreciable degree of
sensitivity failed to reveal comparable
antibody binding to the tumour cells;
and also the demonstration of residual
antibody reactivity against normal lymph-
oid cells following absorption of reference
alloantisera with graded numbers of leuk-
aemic cells. In some instances, such cell
surface changes may be related to serial
in vivo passage, or in the case of P388, to
maintenance in tissue culture. While
this possibility cannot be excluded for
the transplanted leukaemias studied, a
close association with leukaemogenesis
is strongly implied by the finding that
similar modification ofH-2 antigen expres-
sion was a feature common to 9 BNU
induced primary leukaemias.
There are several interpretations of
the apparent diminution in antibody
binding sites on the surface of primary
and transplanted leukaemia cells which
are not necessarily mutually exclusive.
First, H-2 antigens are quantitatively
deleted from the cell surface; second,
the increased volume of leukaemic cells
compared with normal lymphoid cells
brings about spatial redistribution of
antibody binding sites to a density below
the threshold level of detection by IF;
and third, H-2 antigen expression is modi-
fied by other factors such as masking.
Antigens dependent on the H-2 chro-
mosome region in mice comprise many
distinct specificities. The marked reduc-
tion in staining with multispecific H-2
antisera would not be inconsistent with
an overall reduction of all the specificities
or with disappearance of those to which
antibodies were primarily directed. Since
the IF test as employed in this study is
capable of monitoring only gross changes
in H-2 components, no distinction can
be made between these possibilities. Pre-
cedents exist for both: qualitative disap-
pearance of certain antigens on malignant
cells has been claimed (Rubin et al., 1970;
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Seigler et al., 1971) while in other cases a
general diminution, without detectable
qualitative loss, has been reported
(Haywood and McKhann, 1971).
No information is available on the
minimum antigen density required for
detection of cell surface components by
IF. It is possible that the five-fold in-
crease in surface area of the leukaemic
cells comparedwithnormal lymphoid cells
might reduce the capability of the test.
However, this was not supported by
absorption studies where exposure ofanti-
serum to a surface area of leukaemic cells
approximately 5 times that of normal
spleen cells failed to abolish the reactivity
of antibody with normal lymphoid cells.
The possibility that H-2 antigens on
the surface of leukaemic cells are non-
exposed or present in cryptic form merits
consideration. Treatment of certain cell
types with neuraminidase reveals other-
wiseconcealedhistocompatibilityantigens,
asdemonstratedbyincreasedsusceptibility
ofcells to the appropriate antibody in vitro
and abrogation of allogeneic transplant-
ability in vivo (Sanford, 1967; Schlesinger
and Amos, 1971; Schlesinger and Gottes-
feld, 1971). Masking phenomena other
than sialic acid coating are known to
exist (Friberg and Lilliehook, 1973). In
several mouse tumour systems failure to
detect H-2 antigens, shownbycellfraction-
ation procedures to be localizedexclusively
in the cell membrane, was attributed to
steric hindrance of cell surface determin-
ants in the leukaemic cells (Molnar, Klein
and Friberg, 1973). Masking of antigen,
as distinct from deletion, possibly accounts
more adequately for the humoral antibody
response generated against H-2 antigens
in allogeneic mice. However, the degree
to which unavoidable contamination of
the immunizing leukaemia cell prepa-
rations with a small minority of normal
lymphoid cells contributes tothis antibody
induction is difficult to assess quantita-
tively and should not be disregarded.
Most experimentally induced leukae-
mias express neoantigens detectable
serologically or by in vivo transplantation
procedures (Pasternak, 1969). In the
present study only 2 of 5 transplanted
leukaemias provided any evidence of
immunogenicity, and this was weak.
The association ofthis property with P388
leukaemia cells in particular is obscure.
This might reflect histocompatibility
differences between tumour and host,
culminating from a long history of trans-
plantation andin vitro culture, orantigenic
conversion (Stuck, Old and Boyse, 1964),
an interpretation consistent with the
large numbers ofvirus particles associated
with this neoplasm (T. D. Allen, personal
communication).
Attempts to induce resistance against
3 other transplanted leukaemias in this
study were unsuccessful. Several possi-
bilities might account for this apparent
lack of neoantigenicity, e.g. the deficiency
may be intrinsic or a consequence of
immuno selection. However, since some
murine lymphomata exist for which the
LD50 in syngeneic recipients is only a few
cells, the requirement of 103 cells to en-
sure leukaemia development implies some
resistance on the part of the host. This
being so, failure to significantly augment
this protection by immunization, other
than in an apparently nonspecific way, or
to induce synthesis of specific antibody,
may be a reflection of the inadequacy of
the immunization protocol rather than
lack of immunogenicity. However,
alternative methods ofinducing resistance
or raising antibody using mitomycin-C
treated cells or subthreshold inocula have
not proved cignificantly better (unpub-
lished finding}. These data would not
therefore beinconconsistentwiththehypo-
thesis that failure to detect unequivocally
tumour neoantigens on these leukaemias
is related to complex cell surface changes
affecting antigen expression as a whole.
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